29 results
Thumbnail

D1.39 - Differential Diagnosis of Perioperative Anaphylaxis: The Hidden Role of Chlorhexidine

Thumbnail

D1.28 - Anaphylaxis after appendectomy: A case of allergy to sugammadex

Thumbnail

D1.29 - Class III Chitinases as Potential Allergens in Raspberry-Induced Anaphylaxis

Thumbnail

D1.30 - An exotic anaphylaxis in the mediterranean: due to a clinical case

Thumbnail

D1.31 - Quality Of Life In Alexithymic Patients With Anaphylaxis

Thumbnail

D1.32 - The effect of chelation on carmine allergy induced by epicutaneous sensitization to carmine in cosmetics

Thumbnail

D1.33 - Oat Allergy in a Young Adult: Allergenic Protein Profiling and Clinical Implications

Thumbnail

D1.34 - Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Thumbnail

D1.35 - Lipid transfer protein and Profilin-associated food-dependent exercise-induced anaphylaxis: A case series

Thumbnail

D1.36 - Prevalence of thaumatin and Alternaria co-sensitization

Thumbnail

D1.42 - Case Report of Allergy to Mint and Basil

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Thumbnail

D1.37 - Sometimes it is not what it seems

Thumbnail

D1.38 - Anaphylactic reaction to chia seeds: A case report

Thumbnail

D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma

Thumbnail

D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)

Thumbnail

D1.152 - Incidence of patients who needed to change their allergy immunotherapy product specific to mites or pollens in Spanish allergy unitsIncidence of switching specific allergic immunotherapy products in Spanish allergy units

Thumbnail

D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites

Thumbnail

D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Thumbnail

D1.155 - Alterations in B cell memory induced by house dust mite allergen immunotherapy